NCT05507879View on ClinicalTrials.gov

TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

September 26, 2022

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2027

Conditions
Breast CarcinomaCardiomyopathyCongestive Heart Failure
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

OTHER

Electronic Medical Record

Review of medical records

Trial Locations (2)

32610

RECRUITING

University of Florida, Gainesville

32224-9980

RECRUITING

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05507879 - TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer | Biotech Hunter | Biotech Hunter